Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Breast Imaging Devices Markets Report 2021-2030: Tomosynthesis, Ultrasound, MRI, Mammography, Nuclear Imaging, Ionizing, Non Ionizing


DUBLIN, Aug. 4, 2021 /PRNewswire/ -- The "Breast Imaging Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global breast imaging devices market is expected to grow from $3.461 billion in 2020 to $3.754 billion in 2021 at a compound annual growth rate (CAGR) of 8.5%. 

Major players in the breast imaging devices market are Siemens Healthcare, GE Healthcare, Dilon Technologies Inc., Hologic, Inc., Gamma Medica Inc., Fujifilm Holdings Corporation, SonoCine Inc, Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology Inc.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.091 billion in 2025 at a CAGR of 13%.

The breast imaging devices market consists of sales of breast imaging devices and related services by entities (organizations, sole traders, and partnerships) that manufacture breast imaging devices. Breast imaging devices are medical devices used in the diagnosis of medical conditions related to the breast. Some of the breast imaging processes include mammography, MRI, and ultrasound.

Major players operating in breast imaging devices market are undertaking various strategic initiatives such as the launch of technologically advanced or innovative products and product portfolio expansion, which is likely to be a leading trend in the breast imaging market. Various companies are introducing new advanced devices in the market to attract a large customer base and maintain their position in the competitive business environment. 

The breast imaging devices market covered in this report is segmented by product type into tomosynthesis; breast ultrasound; breast MRI; mammography; nuclear imaging; others. It is also segmented by technology into ionizing; non ionizing, and by end user into hospitals and clinics; breast care centers; diagnostic imaging centers.

In June 2019, Hologic, Inc., a USA-based innovative medical technology company focused on improving women's health and well-being through early treatment and diagnosis, announced the acquisition of SuperSonic Imagine for an amount of $85 million. With the acquisition of SuperSonic Imagine, Hologic, Inc. aims to gain entry in cart-based breast ultrasound technology used to screen women with dense breast tissue. SuperSonic Imagine is a France-based company specialized in ultrasound medical imaging including breast imaging devices.

The rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market's growth. A growing number of hormone replacement therapy (HRT), hormonal imbalances, menopause, and various reproductive disorders have significantly increased the risks of breast cancer. According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.1 million women annually. 

High cost associated with breast imaging devices is expected to limit the growth of the market in the near future. The cost of digital mammography systems varies for different models and companies. For instance, the cost of the 2D model's mammography systems ranges between $65,000 to $95,000 for GE Healthcare and Hologic, Inc products.

Whereas 3D models of the same company's range between $90,000 to $200,000. In addition to this, the premium 3D models of GE Healthcare and Hologic Inc. are priced between $1,40,000 to $2,75,000. Therefore, the high cost of breast imaging systems is a major concern for end-users, which is predicted to hinder the growth of breast imaging devices market over the forecast period.

Key Topics Covered:

1. Executive Summary

2. Breast Imaging Devices Market Characteristics

3. Breast Imaging Devices Market Trends and Strategies

4. Impact of COVID-19 on Breast Imaging Devices

5. Breast Imaging Devices Market Size and Growth
5.1. Global Breast Imaging Devices Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Breast Imaging Devices Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Breast Imaging Devices Market Segmentation
6.1. Global Breast Imaging Devices Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

6.2. Global Breast Imaging Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

6.3. Global Breast Imaging Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7. Breast Imaging Devices Market Regional and Country Analysis
7.1. Global Breast Imaging Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Breast Imaging Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/tj2emx

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 08:10
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a leading home health care organization, is pleased to announce that it placed No. 42 on the 2021 Report on Business ranking of Canada's Top Growing Companies. Canada's Top Growing Companies...

at 08:05
Ventus Therapeutics, Inc., a biotechnology company using structure-based drug design to advance a pipeline of small molecule medicines for high-value targets, presented data for its NLRP3 inhibitor program at today's 2021 EMBO Inflammasome Workshop....

at 08:05
A group of long-time stockholders (the "Nominating Stockholders" or the "Group") of CytoDyn Inc. ("CYDY or the "Company") that has nominated five highly experienced director candidates to serve on the Company's Board of Directors today announced its...

at 08:05
The "Single-Use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to...

at 08:00
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its...

at 08:00
Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Participants will be available to answer questions from the media following their remarks. DateSeptember 24, 2021 Time11:00 AM (EDT)...



News published on 4 august 2021 at 15:15 and distributed by: